| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/16/1999 | CA2011116C Lyophilized bmy-28142 dihydrochloride for parenteral use |
| 11/16/1999 | CA2010272C Benzenesulfonamides and a process for their preparation |
| 11/16/1999 | CA2002864C (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
| 11/15/1999 | CA2272042A1 Pharmaceutical formulations of sildenafil |
| 11/14/1999 | CA2271582A1 Method for administration of therapeutic agents, including antisense, with repeat dosing |
| 11/14/1999 | CA2270022A1 Combination of dofetilide and a calcium channel blocker |
| 11/13/1999 | CA2271267A1 Overexpressing human methenyltetrahydrofolate synthetase to sensitize cancer cells to 5-fluorouracil cytotoxicity |
| 11/13/1999 | CA2248987A1 Novel compounds |
| 11/11/1999 | WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 11/11/1999 | WO1999057301A1 Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof |
| 11/11/1999 | WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 11/11/1999 | WO1999057238A1 Stable carbanilide composition |
| 11/11/1999 | WO1999057136A2 Binding partner and method for the competitive inhibition of binding between nef protein and calmodulin, agent containing said binding partner and it use in hiv-related diseases |
| 11/11/1999 | WO1999057135A1 Antipicornaviral compounds, their preparation and use |
| 11/11/1999 | WO1999057131A1 Method of treating bladder and lower urinary tract syndromes |
| 11/11/1999 | WO1999057127A1 2'-deoxy hygromycin derivatives |
| 11/11/1999 | WO1999057126A1 Novel anthracycline derivatives and their preparation |
| 11/11/1999 | WO1999057125A2 Hygromycin a derivatives |
| 11/11/1999 | WO1999057124A1 Monomeric, oligomeric and polymeric knoevenagel condensation products |
| 11/11/1999 | WO1999057121A1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 11/11/1999 | WO1999057118A1 Novel n-oxides |
| 11/11/1999 | WO1999057117A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 11/11/1999 | WO1999057115A1 Novel benzimidazoles and benzoxazoles |
| 11/11/1999 | WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 11/11/1999 | WO1999057113A1 Heterocyclic derivatives which inhibit factor xa |
| 11/11/1999 | WO1999057112A1 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
| 11/11/1999 | WO1999057102A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 11/11/1999 | WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors |
| 11/11/1999 | WO1999057100A1 Spla2 inhibitor compounds for treatment of disease |
| 11/11/1999 | WO1999057099A1 Heterocyclic derivatives which inhibit factor xa |
| 11/11/1999 | WO1999057096A1 Biphenyl derivatives |
| 11/11/1999 | WO1999056850A1 Chelate-forming filter, process for producing the same, and method of purifying liquid with the filter |
| 11/11/1999 | WO1999056799A1 Stabilised compositions containing hyaluronic acid, their preparation and use |
| 11/11/1999 | WO1999056784A2 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
| 11/11/1999 | WO1999056781A1 Methods of using isomer enriched conjugated linoleic acid compositions |
| 11/11/1999 | WO1999056780A1 Isomer enriched conjugated linoleic acid compositions |
| 11/11/1999 | WO1999056773A2 Composition comprising tumor cells and extracts and method of using thereof |
| 11/11/1999 | WO1999056768A1 Methods for treating diabetes by inhibiting gdf-8 |
| 11/11/1999 | WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 11/11/1999 | WO1999056761A1 Methods for treatment of pain |
| 11/11/1999 | WO1999056756A1 Use of a fluoride ion vector for preparing a medicine for preventing or treating diseases associated with helicobacter pylori |
| 11/11/1999 | WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | WO1999056754A1 COMPOSITIONS CONTAINING AN α1,2-FUCOSE LINKAGE AND USES THEREOF |
| 11/11/1999 | WO1999056753A1 Hematopoietic stimulation |
| 11/11/1999 | WO1999056752A1 sPLA2 INHIBITOR ESTER |
| 11/11/1999 | WO1999056751A1 Aqueous process for manufacturing paroxetine solid dispersions |
| 11/11/1999 | WO1999056750A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders |
| 11/11/1999 | WO1999056748A1 Desmethylpantoprazole compositions and methods |
| 11/11/1999 | WO1999056747A1 Compositions and methods for treating particular chemical addictions and mental illnesses |
| 11/11/1999 | WO1999056746A1 Hydroxyomeprazole compositions and uses |
| 11/11/1999 | WO1999056745A1 New use |
| 11/11/1999 | WO1999056744A1 Immunosuppressant containing glucopyranose derivative as active ingredient |
| 11/11/1999 | WO1999056743A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations |
| 11/11/1999 | WO1999056742A1 Chemotherapeutic treatment |
| 11/11/1999 | WO1999056741A1 Methods for treating female sexual dysfunction |
| 11/11/1999 | WO1999056740A1 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay |
| 11/11/1999 | WO1999056739A1 A method for chemoprevention of prostate cancer |
| 11/11/1999 | WO1999056738A1 Use of triclosan for the treatment of helicobacter pylori infections |
| 11/11/1999 | WO1999056737A1 Arylhydrocarbon receptor ligand antagonists |
| 11/11/1999 | WO1999056736A2 Apoptosis-inducing compounds |
| 11/11/1999 | WO1999056735A2 Use of antioxidants for the treatment of inflammatory skin diseases |
| 11/11/1999 | WO1999056734A2 Transdermal therapeutic system for the administration of candesartan |
| 11/11/1999 | WO1999056729A1 Cholesterol lowering composition |
| 11/11/1999 | WO1999056728A1 Pge-1 containing lyopholized liposomes for use in the treatment of erectile dysfunction |
| 11/11/1999 | WO1999056719A1 Skin care agents containing combinations of active agents consisting of vitamin a derivatives and ubi- or plastoquinones |
| 11/11/1999 | WO1999056698A2 Treatment of celiac disease |
| 11/11/1999 | WO1999056697A2 Pharmaceutical composition |
| 11/11/1999 | WO1999056666A1 The treatment of sexual dysfunction in certain patient groups |
| 11/11/1999 | WO1999056558A1 Phytosterol compositions |
| 11/11/1999 | WO1999056552A1 Method of hsv prophylaxis |
| 11/11/1999 | WO1999056550A1 Method for treating migraine in mammals |
| 11/11/1999 | WO1999056545A1 Hair and skin treatment method and composition |
| 11/11/1999 | WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 11/11/1999 | WO1999048901A3 Sucrose-n-alkyl-asparaginates, production and use thereof |
| 11/11/1999 | WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 11/11/1999 | WO1999046240A3 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 11/11/1999 | WO1999045916A3 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected |
| 11/11/1999 | WO1999045906A8 Treatment of compulsive behaviours in man and animals |
| 11/11/1999 | WO1999045016A9 Novel prodrugs for phosphorus-containing compounds |
| 11/11/1999 | WO1999044988A3 Method for preparing sulfanyl-type endothelin receptor antagonists |
| 11/11/1999 | WO1999043354A3 Method for treating painful conditions of the anal region and compositions therefor |
| 11/11/1999 | WO1999042821A3 Treating cancer |
| 11/11/1999 | WO1999042574B1 Sequences of an ih ionic channel and the use thereof |
| 11/11/1999 | WO1999040083A3 Bifunctional tryptase inhibitors |
| 11/11/1999 | WO1999040073A3 Tryptase inhibitors |
| 11/11/1999 | WO1998004528A3 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents |
| 11/11/1999 | DE3348492C2 Di:hydro-poly:prenyl alcohol and ester and ether derivs. |
| 11/11/1999 | DE19838506A1 Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen The indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferations |
| 11/11/1999 | DE19831579A1 Antikrebstherapiemittel aus Arsenhexoxid Anti-cancer therapeutics from Arsenhexoxid |
| 11/11/1999 | DE19820599A1 New epothilone derivatives useful as pharmaceuticals and in plant protection |
| 11/11/1999 | DE19820392A1 Wirkstoffkombinationen enthaltende Hautpflegemittel Drug combinations containing skin care products |
| 11/11/1999 | DE19820151A1 Transdermales therapeutisches System zur Anwendung von Candesartan Transdermal therapeutic system for application of candesartan |
| 11/11/1999 | DE19820064A1 Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted Sulfonylcyanamide, processes for their preparation and their use as a medicament |
| 11/11/1999 | DE19819975A1 Unit for simultaneous photodynamic and hyperthermal therapy of tumors avoiding harm to surrounding tissues |
| 11/11/1999 | DE19819703A1 New composition useful as insect repellant also has antiinflammatory and antipruritic activity |
| 11/11/1999 | DE19819616A1 Verwendung von Antioxidantien zur Behandlung von entzündlichen Hauterkrankungen The use of antioxidants in the treatment of inflammatory skin diseases |
| 11/11/1999 | DE19818955A1 Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat Composition containing polyacrylate, polyterpene, nitroglycerin, and optionally, polyvinyl acetate |
| 11/11/1999 | DE19818419A1 Treatment of generalized chlamydia infections |
| 11/11/1999 | DE19813802A1 Anti-virale Wirkung von Propolis durch Inhibition viraler Nukleinsäure Polymerasen Anti-viral activity of propolis by inhibition of viral nucleic acid polymerases |
| 11/11/1999 | DE19805815C1 Diagnostikum zum Erkennen der autoimmunen Hepatitis Diagnostic tool for the detection of autoimmune hepatitis |